-
1
-
-
0344171979
-
Common musculoskeletal tumors of childhood and adolescence
-
Arndt CA, Crist WM. 1999. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341:342-352.
-
(1999)
N Engl J Med
, vol.341
, pp. 342-352
-
-
Arndt, C.A.1
Crist, W.M.2
-
2
-
-
63449118087
-
Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program
-
Mirabello L, Troisi RJ, Savage SA. 2009. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 115:1531-1543.
-
(2009)
Cancer
, vol.115
, pp. 1531-1543
-
-
Mirabello, L.1
Troisi, R.J.2
Savage, S.A.3
-
4
-
-
0036554816
-
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention
-
Buettner R, Mora LB, Jove R. 2002. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8:945-954. (Pubitemid 35177340)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.4
, pp. 945-954
-
-
Buettner, R.1
Mora, L.B.2
Jove, R.3
-
5
-
-
20944435625
-
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells
-
Nam S, Buettner R, Turkson J, et al. 2005. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci USA 102:5998-6003.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 5998-6003
-
-
Nam, S.1
Buettner, R.2
Turkson, J.3
-
6
-
-
34548526140
-
Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells
-
Chen CL, Loy A, Cen L, et al. 2007. Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells. BMC Cancer 7:111.
-
(2007)
BMC Cancer
, vol.7
, pp. 111
-
-
Chen, C.L.1
Loy, A.2
Cen, L.3
-
7
-
-
33845865865
-
The STAT3 oncogene as a predictive marker of drug resistance
-
Barre B, Vigneron A, Perkins N, et al. 2007. The STAT3 oncogene as a predictive marker of drug resistance. Trends Mol Med 13:4-11.
-
(2007)
Trends Mol Med
, vol.13
, pp. 4-11
-
-
Barre, B.1
Vigneron, A.2
Perkins, N.3
-
8
-
-
33645242181
-
STAT3 is activated in a subset of the Ewing sarcoma family of tumours
-
Lai R, Navid F, Rodriguez-Galindo C, et al. 2006. STAT3 is activated in a subset of the Ewing sarcoma family of tumours. J Pathol 208:624-632.
-
(2006)
J Pathol
, vol.208
, pp. 624-632
-
-
Lai, R.1
Navid, F.2
Rodriguez-Galindo, C.3
-
9
-
-
58849152837
-
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells
-
Duan Z, Ames RY, Ryan M, et al. 2009. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemother Pharmacol 63:681-689.
-
(2009)
Cancer Chemother Pharmacol
, vol.63
, pp. 681-689
-
-
Duan, Z.1
Ames, R.Y.2
Ryan, M.3
-
10
-
-
0242285719
-
STAT proteins: From normal control of cellular events to tumorigenesis
-
Calo V, Migliavacca M, Bazan V, et al. 2003. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197:157-168.
-
(2003)
J Cell Physiol
, vol.197
, pp. 157-168
-
-
Calo, V.1
Migliavacca, M.2
Bazan, V.3
-
11
-
-
64849088550
-
Characterization of STAT3 activation and expression in canine and human osteosarcoma
-
Fossey SL, Liao AT, McCleese JK, et al. 2009. Characterization of STAT3 activation and expression in canine and human osteosarcoma. BMC Cancer 9:81.
-
(2009)
BMC Cancer
, vol.9
, pp. 81
-
-
Fossey, S.L.1
Liao, A.T.2
McCleese, J.K.3
-
12
-
-
20444446371
-
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors
-
Alvarez JV, Febbo PG, Ramaswamy S, et al. 2005. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Cancer Res 65:5054-5062.
-
(2005)
Cancer Res
, vol.65
, pp. 5054-5062
-
-
Alvarez, J.V.1
Febbo, P.G.2
Ramaswamy, S.3
-
13
-
-
1042302005
-
The stats of cancer - New molecular targets come of age
-
Yu H, Jove R. 2004. The STATs of cancer - new molecular targets come of age. Nat Rev Cancer 4:97-105. (Pubitemid 38198738)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.2
, pp. 97-105
-
-
Yu, H.1
Jove, R.2
-
14
-
-
0034657336
-
The role of STATs in transcriptional control and their impact on cellular function
-
Bromberg J, Darnell JE Jr. 2000. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468-2473. (Pubitemid 30339202)
-
(2000)
Oncogene
, vol.19
, Issue.21
, pp. 2468-2473
-
-
Bromberg, J.1
Darnell Jr., J.E.2
-
15
-
-
12444287592
-
- anaplastic large cell lymphoma
-
Khoury JD, Medeiros LJ, Rassidakis GZ, et al. 2003. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. Clin Cancer Res 9:3692-3699. (Pubitemid 37169237)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.10 I
, pp. 3692-3699
-
-
Khoury, J.D.1
Medeiros, L.J.2
Rassidakis, G.Z.3
Yared, M.A.4
Tsioli, P.5
Leventaki, V.6
Schmitt-Graeff, A.7
Herling, M.8
Amin, H.M.9
Lai, R.10
-
16
-
-
0037096876
-
Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma
-
Masuda M, Suzui M, Yasumatu R, et al. 2002. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 62:3351-3355. (Pubitemid 34651376)
-
(2002)
Cancer Research
, vol.62
, Issue.12
, pp. 3351-3355
-
-
Masuda, M.1
Suzui, M.2
Yasumatu, R.3
Nakashima, T.4
Kuratomi, Y.5
Azuma, K.6
Tomita, K.7
Komiyama, S.8
Weinstein, I.B.9
-
17
-
-
0036075424
-
Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: A study of incidence and its association with pathological features and clinical outcome
-
Horiguchi A, Oya M, Shimada T, et al. 2002. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. J Urol 168:762-765. (Pubitemid 34793359)
-
(2002)
Journal of Urology
, vol.168
, Issue.2
, pp. 762-765
-
-
Horiguchi, A.1
Oya, M.2
Shimada, T.3
Uchida, A.4
Marumo, K.5
Murai, M.6
-
18
-
-
0036093058
-
Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
-
Benekli M, Xia Z, Donohue KA, et al. 2002. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. Blood 99:252-257.
-
(2002)
Blood
, vol.99
, pp. 252-257
-
-
Benekli, M.1
Xia, Z.2
Donohue, K.A.3
-
19
-
-
0037316938
-
Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis
-
Dolled-Filhart M, Camp RL, Kowalski DP, et al. 2003. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Clin Cancer Res 9:594-600. (Pubitemid 36182589)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.2
, pp. 594-600
-
-
Dolled-Filhart, M.1
Camp, R.L.2
Kowalski, D.P.3
Smith, B.L.4
Rimm, D.L.5
-
20
-
-
0041620205
-
Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis
-
Hsiao JR, Jin YT, Tsai ST, et al. 2003. Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. Br J Cancer 89:344-349.
-
(2003)
Br J Cancer
, vol.89
, pp. 344-349
-
-
Hsiao, J.R.1
Jin, Y.T.2
Tsai, S.T.3
-
21
-
-
53349153184
-
Prognostic value of signal transducers and activators of transcription 3 in breast cancer
-
Sheen-Chen SM, Huang CC, Tang RP, et al. 2008. Prognostic value of signal transducers and activators of transcription 3 in breast cancer. Cancer Epidemiol Biomarkers Prev 17:2286-2290.
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, pp. 2286-2290
-
-
Sheen-Chen, S.M.1
Huang, C.C.2
Tang, R.P.3
-
22
-
-
0034722896
-
STAT proteins: Novel molecular targets for cancer drug discovery
-
Turkson J, Jove R. 2000. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19:6613-6626.
-
(2000)
Oncogene
, vol.19
, pp. 6613-6626
-
-
Turkson, J.1
Jove, R.2
-
23
-
-
33845310503
-
SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation
-
Duan Z, Bradner JE, Greenberg E, et al. 2006. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation. Clin Cancer Res 12:6844-6852.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6844-6852
-
-
Duan, Z.1
Bradner, J.E.2
Greenberg, E.3
-
24
-
-
35548976764
-
8-Benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells
-
Duan Z, Bradner J, Greenberg E, et al. 2007. 8-Benzyl-4-oxo-8- azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells. Mol Pharmacol 72:1137-1145.
-
(2007)
Mol Pharmacol
, vol.72
, pp. 1137-1145
-
-
Duan, Z.1
Bradner, J.2
Greenberg, E.3
-
25
-
-
0036782706
-
Transcription factors as targets for cancer therapy
-
Darnell JE Jr. 2002. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2:740-749.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 740-749
-
-
Darnell Jr., J.E.1
-
26
-
-
0033555614
-
A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9- dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity
-
Suh N, Wang Y, Honda T, et al. 1999. A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. Cancer Res 59:336-341.
-
(1999)
Cancer Res
, vol.59
, pp. 336-341
-
-
Suh, N.1
Wang, Y.2
Honda, T.3
-
27
-
-
0141507973
-
Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells
-
Lapillonne H, Konopleva M, Tsao T, et al. 2003. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Cancer Res 63:5926-5939. (Pubitemid 37187494)
-
(2003)
Cancer Research
, vol.63
, Issue.18
, pp. 5926-5939
-
-
Lapillonne, H.1
Konopleva, M.2
Tsao, T.3
Gold, D.4
McQueen, T.5
Sutherland, R.L.6
Madden, T.7
Andreeff, M.8
-
28
-
-
21144438719
-
Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells
-
Hyer ML, Croxton R, Krajewska M, et al. 2005. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Cancer Res 65:4799-4808.
-
(2005)
Cancer Res
, vol.65
, pp. 4799-4808
-
-
Hyer, M.L.1
Croxton, R.2
Krajewska, M.3
-
29
-
-
33644979262
-
Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells
-
Konopleva M, Zhang W, Shi YX, et al. 2006. Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells. Mol Cancer Ther 5:317-328.
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 317-328
-
-
Konopleva, M.1
Zhang, W.2
Shi, Y.X.3
-
30
-
-
42349104546
-
Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1) → signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3
-
Ahmad R, Raina D, Meyer C, Kufe D. 2008. Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1) → signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3. Cancer Res 68:2920-2926.
-
(2008)
Cancer Res
, vol.68
, pp. 2920-2926
-
-
Ahmad, R.1
Raina, D.2
Meyer, C.3
Kufe, D.4
-
31
-
-
0032711015
-
Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: Analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype
-
Duan Z, Feller AJ, Penson RT, et al. 1999. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. Clin Cancer Res 5:3445-3453.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 3445-3453
-
-
Duan, Z.1
Feller, A.J.2
Penson, R.T.3
-
32
-
-
33845713308
-
Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/ Apolipoprotein J
-
Lourda M, Trougakos IP, Gonos ES. 2007. Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/ Apolipoprotein J. Int J Cancer 120:611-622.
-
(2007)
Int J Cancer
, vol.120
, pp. 611-622
-
-
Lourda, M.1
Trougakos, I.P.2
Gonos, E.S.3
-
33
-
-
33748992592
-
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer
-
Duan Z, Foster R, Bell DA, et al. 2006. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res 12:5055-5063.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5055-5063
-
-
Duan, Z.1
Foster, R.2
Bell, D.A.3
-
34
-
-
0037625216
-
Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicinresistant human cancer cell lines
-
Duan Z, Duan Y, Lamendola DE, et al. 2003. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin Cancer Res 9:2778-2785. (Pubitemid 36842124)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.7
, pp. 2778-2785
-
-
Duan, Z.1
Duan, Y.2
Lamendola, D.E.3
Yusuf, R.Z.4
Naeem, R.5
Penson, R.T.6
Seiden, M.V.7
-
35
-
-
23444452377
-
Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors
-
Kusaba T, Nakayama T, Yamazumi K, et al. 2005. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol 58:833-838.
-
(2005)
J Clin Pathol
, vol.58
, pp. 833-838
-
-
Kusaba, T.1
Nakayama, T.2
Yamazumi, K.3
-
36
-
-
21044447810
-
Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma
-
Suiqing C, Min Z, Lirong C. 2005. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma. J Dermatol 32:354-360. (Pubitemid 40874460)
-
(2005)
Journal of Dermatology
, vol.32
, Issue.5
, pp. 354-360
-
-
Suiqing, C.1
Min, Z.2
Lirong, C.3
-
37
-
-
34047259844
-
Expression of p-STAT3 in human gastric carcinoma: Significant correlation in tumour invasion and prognosis
-
Yakata Y, Nakayama T, Yoshizaki A, et al. 2007. Expression of p-STAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis. Int J Oncol 30:437-442.
-
(2007)
Int J Oncol
, vol.30
, pp. 437-442
-
-
Yakata, Y.1
Nakayama, T.2
Yoshizaki, A.3
-
38
-
-
33751575658
-
The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis
-
Rosen DG, Mercado-Uribe I, Yang G, et al. 2006. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 107:2730-2740.
-
(2006)
Cancer
, vol.107
, pp. 2730-2740
-
-
Rosen, D.G.1
Mercado-Uribe, I.2
Yang, G.3
-
39
-
-
69449106152
-
MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion
-
Gao J, McConnell MJ, Yu B, et al. 2009. MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion. Int J Oncol 35:337-345.
-
(2009)
Int J Oncol
, vol.35
, pp. 337-345
-
-
Gao, J.1
McConnell, M.J.2
Yu, B.3
-
40
-
-
54249083133
-
Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation
-
Qin HR, Kim HJ, Kim JY, et al. 2008. Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. Cancer Res 68:7736-7741.
-
(2008)
Cancer Res
, vol.68
, pp. 7736-7741
-
-
Qin, H.R.1
Kim, H.J.2
Kim, J.Y.3
-
41
-
-
70350541138
-
STAT3 as a central regulator of tumor metastases
-
Devarajan E, Huang S. 2009. STAT3 as a central regulator of tumor metastases. Curr Mol Med 9:626-633.
-
(2009)
Curr Mol Med
, vol.9
, pp. 626-633
-
-
Devarajan, E.1
Huang, S.2
-
42
-
-
40949124676
-
Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes
-
Seethala RR, Gooding WE, Handler PN, et al. 2008. Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes. Clin Cancer Res 14:1303-1309.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 1303-1309
-
-
Seethala, R.R.1
Gooding, W.E.2
Handler, P.N.3
-
43
-
-
70149099358
-
Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression
-
Ranger JJ, Levy DE, Shahalizadeh S, et al. 2009. Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression. Cancer Res 69:6823-6830.
-
(2009)
Cancer Res
, vol.69
, pp. 6823-6830
-
-
Ranger, J.J.1
Levy, D.E.2
Shahalizadeh, S.3
-
44
-
-
0023732557
-
Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13- acetate by some oleanane-type triterpenoid compounds
-
Nishino H, Nishino A, Takayasu J, et al. 1988. Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds. Cancer Res 48:5210-5215.
-
(1988)
Cancer Res
, vol.48
, pp. 5210-5215
-
-
Nishino, H.1
Nishino, A.2
Takayasu, J.3
-
45
-
-
0027982986
-
Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid
-
Huang MT, Ho CT, Wang ZY, et al. 1994. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 54:701-708.
-
(1994)
Cancer Res
, vol.54
, pp. 701-708
-
-
Huang, M.T.1
Ho, C.T.2
Wang, Z.Y.3
-
46
-
-
34247526984
-
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
-
Liby KT, Yore MM, Sporn MB. 2007. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer 7:357-369.
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 357-369
-
-
Liby, K.T.1
Yore, M.M.2
Sporn, M.B.3
|